Patel Amends Amneal Pharma Stake Filing
Ticker: AMRX · Form: SC 13D/A · Filed: May 13, 2024 · CIK: 1723128
Sentiment: neutral
Topics: sec-filing, schedule-13d, beneficial-ownership
Related Tickers: AMRX
TL;DR
Tushar Patel updated his Amneal Pharma (AMRX) filing on 5/9. Check the details.
AI Summary
On May 9, 2024, Tushar Bhikhubhai Patel filed an amendment (Amendment No. 4) to Schedule 13D for Amneal Pharmaceuticals, Inc. The filing indicates a change in beneficial ownership of the company's Class A Common Stock. Patel's address is listed as c/o Tarsadia Investments in Newport Beach, CA.
Why It Matters
This filing signals a potential shift in significant shareholder positions, which could influence market perception and trading activity for Amneal Pharmaceuticals.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant changes in a major shareholder's stake, which can lead to increased volatility.
Key Numbers
- 005-90473 — SEC File Number (Identifies the specific SEC filing for Amneal Pharmaceuticals)
Key Players & Entities
- Amneal Pharmaceuticals, Inc. (company) — Subject company
- Tushar Bhikhubhai Patel (person) — Filing person
- Tarsadia Investments, LLC (company) — Address for filing person
- May 9, 2024 (date) — Date of event requiring filing
FAQ
What specific changes in beneficial ownership are reported in this Amendment No. 4?
The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership, but the specific details of the change (e.g., number of shares, percentage) are not provided in the excerpt.
Who is Tushar Bhikhubhai Patel in relation to Amneal Pharmaceuticals?
Tushar Bhikhubhai Patel is the person filing this Schedule 13D/A, indicating he is a significant beneficial owner of Amneal Pharmaceuticals, Inc.
What is the purpose of a Schedule 13D filing?
A Schedule 13D is filed by any person or group who acquires beneficial ownership of more than five percent of a class of the issuer's equity securities.
What does the 'FORM TYPE: SC 13D/A' signify?
SC 13D/A signifies an amendment to a Schedule 13D filing, meaning there has been a material change in the information previously reported.
Where is Tushar Patel's mailing address listed for this filing?
Tushar Patel's mailing address is listed as c/o Tarsadia Investments, 520 Newport Center Drive, 21st Floor, Newport Beach, CA 92660.
Filing Stats: 1,247 words · 5 min read · ~4 pages · Grade level 11.1 · Accepted 2024-05-13 16:15:28
Key Financial Figures
- $0.01 — ssuer) Class A Common Stock, par value $0.01 (Title of Class of Securities) 03168L
Filing Documents
- sc13d-a.htm (SC 13D/A) — 63KB
- exh99-5.htm (EX-99.5) — 88KB
- exh99-6.htm (EX-99.6) — 33KB
- 0000898432-24-000401.txt ( ) — 184KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : May 13, 2024 /s/ Tushar Patel Tushar Patel